Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CANF will decline by -2.96% over the next 2 Weeks and hit $0.66 by Wednesday, August 13, 2025. In that time frame, CANF's share price is expected to range between $0.60 and $0.72.
BearishAverageBullishCANF shares fell -5.26% in Wednesday, July 30, 2025's trading session, dropping from a previous close of $0.71 to move at $0.68. The stock demonstrated notable intraday movement (see CANF's key stats for a full breakdown), fluctuating between $0.66 and $0.70, a +6.87% trading range. While recent weeks have seen some volatility, CANF has managed to secure a -35.62% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 487.63K shares changing hands, 8.25K fewer than the previous session. This amounted to $329.64K in total market activity.
Will CANF Continue Its Upward Trend?
According to analyst ratings and projections for CANF, Can-Fite BioPharma Ltd. shares are anticipated to increase by +6.28%, potentially reaching $0.72 per share by August 13, 2025. Short-term technical indicators currently suggest a neutral sentiment for CANF. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 8 positive trading days within the past 30 sessions. Based on the CANF stock forecast, now is a good time to buy CANF stock because its current trading price is +3.05% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CANF covering social and institutional perspectives.
CANF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CANF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 8.50% to 18.68%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 34.78%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 41.62%, maintains a neutral outlook for the long term. Insights into CANF's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Can-Fite BioPharma Short-Term Forecasts
CANF Forecast For Next 5 Days
Our algorithm anticipates Can-Fite BioPharma (CANF) stock could hit $0.67 by Aug 07, 2025. This represents a -1.39% fall from today's price, following a -34.37% change over the past five days.
CANF Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Can-Fite BioPharma Ltd. (CANF) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.62, which would mean a -8.28% decrease from the current price of $0.68. Projections for this period range from a high of $0.74 to a low of $0.45.
CANF Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Can-Fite BioPharma's price over the next three months point to a rise. CANF stock is expected to peak at $2.09 on Jul 31, 2025 before potentially dipping to $1.02 on Sep 29, 2025. On average, CANF is likely to trade around $1.58 in the coming 90 days.
Can-Fite BioPharma Stock Forecast 2025
Based on our predictive models, Can-Fite BioPharma (CANF) is expected to trade between $1.02 and $2.09 throughout 2025. This would result in an average price of $1.66, potentially offering investors a +145.56% return from current levels.
Can-Fite BioPharma Ltd. Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in July 2025. The price is predicted to move between $1.94 and $2.09, settling at an average of $2.01. This could translate to a +197.34% gain.
August 2025
Based on current market signals, Can-Fite BioPharma Ltd. is projected to trend august 2025. We forecast a trading range from $1.43 to $2.06, with a likely average price of $1.71. Investors could expect a potential return of +152.96%.
September 2025
Our predictive algorithms indicate Can-Fite BioPharma Ltd. stock may see a shift in September 2025. The expected range spans $1.02–$1.65, with an average target of $1.40. This represents a positive outlook and a possible gain of +107.10%.
October 2025
Analyzing established trends, Can-Fite BioPharma Ltd. looks set to move in October 2025. Projections place the stock between $1.02 and $1.87, averaging around $1.61. This suggests a +138.17% gain from current levels.
November 2025
Market indicators suggest Can-Fite BioPharma Ltd. could experience notable changes during November 2025. Prices could fluctuate within $1.24 to $1.80, with a midpoint forecast of $1.65. The stock might deliver a +144.08% gain.
December 2025
Forecasting for December 2025, models estimate that Can-Fite BioPharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $1.05 and $1.92, averaging $1.90. This signals a positive trajectory with potential returns around +181.07%.
January 2026
According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in January 2026. The price is predicted to move between $0.34 and $1.71, settling at an average of $1.60. This could translate to a +136.69% gain.
February 2026
Based on current market signals, Can-Fite BioPharma Ltd. is projected to trend february 2026. We forecast a trading range from $0.00 to $0.98, with a likely average price of $1.24. Investors could expect a potential return of +83.43%.
March 2026
Our predictive algorithms indicate Can-Fite BioPharma Ltd. stock may see a shift in March 2026. The expected range spans $0.00–$0.96, with an average target of $1.53. This represents a positive outlook and a possible gain of +126.33%.
April 2026
Analyzing established trends, Can-Fite BioPharma Ltd. looks set to move in April 2026. Projections place the stock between $0.00 and $0.60, averaging around $0.90. This suggests a +33.14% gain from current levels.
May 2026
Market indicators suggest Can-Fite BioPharma Ltd. could experience notable changes during May 2026. Prices could fluctuate within $0.00 to $0.22, with a midpoint forecast of $1.00. The stock might deliver a +47.93% gain.
June 2026
Forecasting for June 2026, models estimate that Can-Fite BioPharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.02, averaging $0.93. This signals a positive trajectory with potential returns around +37.57%.
July 2026
According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.79. This could translate to a +16.86% gain.
CANF's history of dividends and stock splits also plays a role in long-term investor confidence.